CJC-1295 with DAC (5mg)
Growth Hormone Research
Research Use Only — Not for Human or Veterinarian Administration

CJC-1295 with DAC (5mg)

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analogue conjugated to a reactive linker that binds serum albumin, extending half-life for sustained GH axis research.

CJC-1295 with DAC (5mg)$69.00
View only
View Certificate of AnalysisThird-party HPLC lab report · opens PDF

Mechanism of Action

DAC conjugation enables albumin binding, prolonging circulation time and producing sustained GHRH receptor activation compared to the non-DAC form.

Research Applications

  • Sustained GH axis modulation research
  • Pharmacokinetic half-life comparison studies
  • GHRH receptor signaling assays

Specifications

sequenceGHRH analogue + DAC conjugate
molecular Weight~3647 Da
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water under sterile conditions.

Storage & Handling

Lyophilized: 2–8 °C. Reconstituted: refrigerate.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Teichman SL, et al. CJC-1295 pharmacokinetics in healthy adults. J Clin Endocrinol Metab. 2006. · PubMed →
  2. 2.Jetté L, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates. Pharm Res. 2005. · PubMed →